Gardella, B.; Agarossi, A.; Dominoni, M.; Pagano, I.; Del Frati, S.; Di Giminiani, M.; Cammarata, S.; Melito, C.; Pasquali, M.F.; Zanchi, L.;
et al. Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up. Vaccines 2023, 11, 265.
https://doi.org/10.3390/vaccines11020265
AMA Style
Gardella B, Agarossi A, Dominoni M, Pagano I, Del Frati S, Di Giminiani M, Cammarata S, Melito C, Pasquali MF, Zanchi L,
et al. Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up. Vaccines. 2023; 11(2):265.
https://doi.org/10.3390/vaccines11020265
Chicago/Turabian Style
Gardella, Barbara, Alberto Agarossi, Mattia Dominoni, Isabella Pagano, Susanna Del Frati, Maria Di Giminiani, Selene Cammarata, Chiara Melito, Marianna Francesca Pasquali, Lucia Zanchi,
and et al. 2023. "Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up" Vaccines 11, no. 2: 265.
https://doi.org/10.3390/vaccines11020265
APA Style
Gardella, B., Agarossi, A., Dominoni, M., Pagano, I., Del Frati, S., Di Giminiani, M., Cammarata, S., Melito, C., Pasquali, M. F., Zanchi, L., Savasi, V., & Spinillo, A.
(2023). Risk Analysis Stratification of CIN 2+ Development in a Cohort of Women Living with HIV with Negative Pap Smear and HR-HPV Test during a Long-Term Follow-Up. Vaccines, 11(2), 265.
https://doi.org/10.3390/vaccines11020265
